STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more

Summary

The Trump administration is advancing the first government-funded clinical trials of ibogaine to treat opioid addiction and PTSD. AstraZeneca's R&D activities were also mentioned in the article.